ArticleSarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG2025
Time and frequency domain assessment of heart rate variability in patients with pulmonary sarcoidosis.
Article in Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Sarcoidosis and Obstructive Sleep Apnoea: An Intriguing Relationship.The open respiratory medicine journal · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
aimThe association between sarcoidosis and autonomic dysfunction is demonstrated but poorly known. Heart rate variability (HRV) studies can provide a simple, non-invasive analysis of sympathetic and vagal tone in sarcoidosis. To date, the burden of steroid treatment on HRV has not been investigated. We aim to compare the HRV in sarcoidosis with general population and to explorate the burden of steroid treatment in HRV.
methodsProspective analysis of 30 patients enrolled in Sarcoidosis Clinic of Policlinico Gemelli Hospital compared to 72 healthy control subjects. Continuous EKG recording over 24 hours has been performed and HRV was assessed using time and frequency domain analysis. Results were evaluated using a propensity score matching 1:1.
resultsPatients affected by sarcoidosis presented a mean age of 59.7±10.1 y and female gender predominance (n=20, 71.4%) %) while the control group was 54.6±16.0 y. The HRV analysis outlined a remarkable difference when both time / frequency domain were compared to the general, healthy population (ΔSDNN: 89.4±6.7 p=0.0001; ΔrMSSD: 5.7±2.6 p=0.03; ΔLF: 497.0±142.3 p=0.0007; ΔHF: 325.0±159.5 p=0.0442) suggesting a significant impact of sarcoidosis in autonomic activation. Remarkably the lung function tests and scadding stage did not show any relationship with the HRV (p=NS). At the same time, steroid treatment of ≥10 mg/day of prednisone for the previous 3 months was associated with a significant reduction of HRV in time (SDNN: Δ17.2±6.9, p=0.020) and frequency domain (LF: Δ355.2±125.7, p=0.009 and HF: Δ116.2±65.2, p=0.087). Lastly, the propensity score matching did confirm the previous results regarding time/frequency domain analysis.
conclusionsHRV is an effective tool for the autonomic evaluation in patients affected by sarcoidosis. The time (r-MSSD, SDNN, pNN50%) and frequency domain (HF/LF mean) analysis in sarcoidosis suggested that autonomic dysfunction is not related to the lung function or scadding stage though steroid treatment may impact.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.